Clinical Trial Update: Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients [NA]

View source ↗

Summary

A Phase 2 clinical trial of rhythmic light therapy for patients with mild cognitive impairment (related to Alzheimer's disease) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Mild Cognitive Impairment | NA | Status: RECRUITING